Rejected at 8:22 p.m. Jun, 08, 2024 ] by Cameron
Author: adavis98
Related Note: 1488765280375 1
Rationale for change

temporary hypercoagulable state until existing coagulation factors decrease in quantity

Rejection reason

Feels fine as is

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#AMBOSS::Xz09ri #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States #AK_Step2_v12::#FirstAid::07_Hematology::01_Coagulation_Disorders::01_Normal_Hemostasis #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::03_Hypercoagulable_States #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step2_v12::#AMBOSS::wx0hAR #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step2_v12::#UWorld::Step::4736 #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step1_v12::#AMBOSS::tQaXB4 #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step2_v12::#UWorld::COMLEX::101516 #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc